{
    "Trade/Device Name(s)": [
        "QMS Vancomycin"
    ],
    "Submitter Information": "Seradyn, Inc",
    "510(k) Number": "K050419",
    "Predicate Device Reference 510(k) Number(s)": [
        "K813218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LEH"
    ],
    "Summary Letter Date": "April 1, 2005",
    "Summary Letter Received Date": "February 18, 2005",
    "Submission Date": "February 17, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3950"
    ],
    "Regulation Name(s)": [
        "Vancomycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 717 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous particle-enhanced turbidimetric immunoassay",
        "Particle agglutination"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for QMS Vancomycin homogeneous particle-enhanced turbidimetric immunoassay for quantitative measurement of vancomycin in human serum or plasma on the Hitachi 717 analyzer",
    "Indications for Use Summary": "Quantitative determination of vancomycin in human serum or plasma to aid in diagnosis and treatment of overdose and for therapeutic drug monitoring on the Hitachi 717 analyzer",
    "fda_folder": "Toxicology"
}